Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

"The sun is lethal. You don't need to be tanned to be beautiful either, so what if you're pale?" Andrew Lines, 70, from ...

“Libtayo is the first medicine to demonstrate a statistically significant benefit in patients who have high-risk features for recurrence after resection of cutaneous squamous cell carcinoma and ...

What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...

The six scopes cost £115,000, and the fund was provided by the Stars Appeal, the charity for Salisbury District Hospital.

That radiant glow you’re chasing by soaking up the sun could be doing more harm than good by raising your risk for skin ...

After Bicara reported a 12-month OS of 61% for its HPV-negative population last week, biotech Merus shared that its ...

A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...

The global burden of skin cancer is expected to grow as the population aged 65 years and older increases in the next 25 years.

When facing a cancer diagnosis, the usual treatment modalities are surgery, chemotherapy, or radiation therapy. But what if there was another powerful weapon in the fight against cancer you haven’t ...